Manisha Talukdar

Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Short-acting beta agonist, antibiotics, oral corticosteroid and association with mortality and cardiopulmonary events in patients with COPD: a retrospective cohort study in Alberta, Canada.

Short-acting beta agonist, antibiotics, oral corticosteroid and association with mortality and cardiopulmonary events in patients with COPD: a retrospective cohort study in Alberta, Canada.

Journal: BMJ open

Published: January 22, 2025

Healthcare resource utilisation in patients with exacerbations of COPD and associated cardiovascular events: the EXACOS-CV study.

Healthcare resource utilisation in patients with exacerbations of COPD and associated cardiovascular events: the EXACOS-CV study.

Journal: ERJ open research

Published: November 25, 2024

Frequency and severity of COPD exacerbations and future risk of exacerbations and mortality: an observational cohort study in Canada.

Frequency and severity of COPD exacerbations and future risk of exacerbations and mortality: an observational cohort study in Canada.

Journal: BMJ open respiratory research

Published: October 25, 2024

Short-Acting Beta-Agonists, Antibiotics, Oral Corticosteroids, and the Associated Burden of COPD.

Short-Acting Beta-Agonists, Antibiotics, Oral Corticosteroids, and the Associated Burden of COPD.

Journal: CHEST pulmonary

Published: February 19, 2024

Heightened long-term cardiovascular risks after exacerbation of chronic obstructive pulmonary disease.

Heightened long-term cardiovascular risks after exacerbation of chronic obstructive pulmonary disease.

Journal: Heart (British Cardiac Society)

Published: September 20, 2023

Asthma-related emergency admissions and associated healthcare resource use in Alberta, Canada.

Asthma-related emergency admissions and associated healthcare resource use in Alberta, Canada.

Journal: BMJ open respiratory research

Published: July 05, 2023

SABA use as an indicator for asthma exacerbation risk: an observational cohort study (SABINA Canada).

SABA use as an indicator for asthma exacerbation risk: an observational cohort study (SABINA Canada).

Journal: ERJ open research

Published: March 22, 2022

A phenolic small molecule inhibitor of RNase L prevents cell death from ADAR1 deficiency.

A phenolic small molecule inhibitor of RNase L prevents cell death from ADAR1 deficiency.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: September 22, 2020

Sunitinib inhibits RNase L by destabilizing its active dimer conformation.

Sunitinib inhibits RNase L by destabilizing its active dimer conformation.

Journal: The Biochemical journal

Published: March 28, 2020

OAS-RNase L innate immune pathway mediates the cytotoxicity of a DNA-demethylating drug.

OAS-RNase L innate immune pathway mediates the cytotoxicity of a DNA-demethylating drug.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: March 01, 2019

Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer.

Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer.

Journal: The Journal of clinical investigation

Published: June 28, 2017

Structure and mechanism of action of the hydroxy-aryl-aldehyde class of IRE1 endoribonuclease inhibitors.

Structure and mechanism of action of the hydroxy-aryl-aldehyde class of IRE1 endoribonuclease inhibitors.

Journal: Nature communications

Published: January 08, 2014

Showing 1-12 of 13

Last Updated: 09/26/2026